ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Breast Cancer: Working Group Sets Broad Agenda For Genetic Research

January 10, 1997

DCE Board Ok’s New RFA Programs worth $14 Million

June 29, 1990

Freireich Blasts Prevention Advocates, Defends Treatment

September 15, 1978

New Mechanism – Cancer Control Cooperative Groups – Under Consideration By NCUI For Regional Activities

May 11, 1984

House Appropriations Adds $20 Mil. To Bush Request For NCI, Emphasizes Three Cancers

June 28, 1991

Straus asks to “Set Record Straight”

September 2, 1988